ARTICLE | Company News
J&J, Mistubishi Tanabe Pharma deal
February 10, 2017 8:16 PM UTC
Johnson & Johnson’s Janssen Pharmaceutical K.K. unit granted Mitsubishi co-promotion rights to Stelara ustekinumab to treat Crohn’s disease. The human mAb inhibiting IL-12 and IL-23 is under review fo...